{"id":"https://openalex.org/W7166802014","doi":"https://doi.org/10.1201/9781003666844-10","title":"In Silico Toxicokinetics","display_name":"In Silico Toxicokinetics","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7166802014","doi":"https://doi.org/10.1201/9781003666844-10"},"language":"en","primary_location":{"id":"doi:10.1201/9781003666844-10","doi":"https://doi.org/10.1201/9781003666844-10","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003666844-10","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computer Simulations in the Pharmaceutical Industry","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W7166805796","display_name":"Computer Simulations in the Pharmaceutical Industry: Volume 1","relationship":"volume"}],"lineage":["https://openalex.org/W7166802014","https://openalex.org/W7166805796"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5124453905","display_name":"Sohini Chakraborty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sohini Chakraborty","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086179788","display_name":"Hemanth Kumar Boyina","orcid":"https://orcid.org/0000-0003-0803-4400","observed_orcids":["https://orcid.org/0000-0003-0803-4400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hemanth Kumar Boyina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138679948","display_name":"Raghavendra Mitta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raghavendra Mitta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113118593","display_name":"Raghavendra Nayaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raghavendra Nayaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"199","last_page":"220"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/in-silico-admet-prediction","display_name":"in silico ADMET prediction","score":0.8889999985694885},{"id":"https://openalex.org/keywords/drug-toxicity-prediction","display_name":"drug toxicity prediction","score":0.609000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.7319999933242798},{"id":"https://openalex.org/keywords/lipinski-s-rule-of-five","display_name":"Lipinski's rule of five","score":0.9309999942779541},{"id":"https://openalex.org/keywords/veber-s-rule","display_name":"Veber's rule","score":0.8980000019073486},{"id":"https://openalex.org/keywords/qsar-qspr","display_name":"QSAR/QSPR","score":0.9290000200271606},{"id":"https://openalex.org/keywords/machine-learning","display_name":"machine learning","score":0.6809999942779541},{"id":"https://openalex.org/keywords/deep-learning","display_name":"deep learning","score":0.9890000224113464},{"id":"https://openalex.org/keywords/p-glycoprotein-efflux","display_name":"P-glycoprotein efflux","score":0.7879999876022339},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cytochrome-p450-metabolism","display_name":"cytochrome P450 metabolism","score":0.8930000066757202},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.921999990940094},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.9890000224113464},{"id":"https://openalex.org/keywords/carcinogenicity","display_name":"carcinogenicity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/early-drug-development","display_name":"early drug development","score":0.5379999876022339},{"id":"https://openalex.org/keywords/multi-omics-integration","display_name":"multi-omics integration","score":0.7480000257492065},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8140000104904175},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5738999843597412},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5037000179290771},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.48069998621940613},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4740999937057495},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.41929998993873596},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4034999907016754},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3991999924182892},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.39169999957084656},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.359499990940094},{"id":"https://openalex.org/C195289149","wikidata":"https://www.wikidata.org/wiki/Q2256694","display_name":"Toxicokinetics","level":3,"score":0.3531000018119812},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34880000352859497},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.3239000141620636},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3116999864578247},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.30469998717308044},{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.29980000853538513},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.29589998722076416},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.2831999957561493},{"id":"https://openalex.org/C2779535233","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Pharmaceutical drug","level":3,"score":0.2793000042438507},{"id":"https://openalex.org/C188598960","wikidata":"https://www.wikidata.org/wiki/Q7705805","display_name":"Test strategy","level":3,"score":0.2782999873161316},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.26249998807907104}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003666844-10","doi":"https://doi.org/10.1201/9781003666844-10","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003666844-10","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computer Simulations in the Pharmaceutical Industry","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204474287","https://openalex.org/W3175318380","https://openalex.org/W2303998399","https://openalex.org/W7122500712","https://openalex.org/W4389921657","https://openalex.org/W4285504807","https://openalex.org/W1560656736","https://openalex.org/W7118078498","https://openalex.org/W4241692936","https://openalex.org/W2762849219"],"abstract_inverted_index":{"Absorption,":[0],"distribution,":[1,175],"metabolism,":[2],"excretion,":[3],"and":[4,20,30,39,43,51,59,81,84,109,119,123,141,159,182,191,199,201,207,217,220,222,245,251,271,278],"toxicity":[5,52,195,279],"(ADMET)":[6],"profiling":[7],"is":[8],"a":[9,55],"major":[10],"driver":[11],"of":[12,24,45,72,107,130,161,174,215,233,240,284],"drug":[13,73,227],"success,":[14],"controlling":[15],"pharmacokinetic":[16,83],"behavior,":[17],"therapeutic":[18],"effectiveness,":[19],"safety.":[21],"Early":[22],"identification":[23],"ADMET":[25,50,79,133,145,277],"liabilities":[26],"in":[27,69,98,156,252,275],"pharmaceutical":[28,286],"research":[29],"development":[31,228],"(R&D)":[32],"reduces":[33,40],"attrition":[34],"rates,":[35],"optimizes":[36],"candidate":[37],"selection,":[38],"the":[41,78,128,282],"cost":[42],"time":[44],"clinical":[46],"failures.":[47],"In":[48,75],"silico":[49,276],"prediction":[53,280],"offers":[54],"cost-effective,":[56],"ethically":[57],"acceptable,":[58],"rapid":[60,231],"alternative":[61],"to":[62,88],"traditional":[63],"experimental":[64],"methods,":[65],"enabling":[66],"data-driven":[67],"decision-making":[68],"early":[70],"stages":[71],"design.":[74],"this":[76],"chapter,":[77],"paradigm":[80],"key":[82],"toxicological":[85],"parameters":[86],"used":[87],"assess":[89],"drug-like":[90],"properties":[91],"are":[92,96,151,185,255],"introduced.":[93],"Computational":[94],"methodologies":[95],"explored":[97],"detail,":[99],"including":[100],"rule-based":[101],"approaches":[102],"such":[103,196,204,237,263],"as":[104,197,205,238,264],"Lipinski\u2019s":[105],"Rule":[106],"Five":[108],"Veber\u2019s":[110],"rules,":[111],"predictive":[112,162],"modeling":[113,188],"using":[114],"quantitative":[115],"structure\u2013activity/property":[116],"relationships":[117],"(QSAR/QSPR),":[118],"sophisticated":[120],"machine":[121],"learning":[122,125],"deep":[124],"algorithms":[126],"for":[127,153,166,230],"capture":[129],"complex,":[131],"nonlinear":[132],"relationships.":[134],"Public":[135],"databases":[136,219],"(e.g.,":[137,144,168],"ChEMBL,":[138],"PubChem,":[139],"Tox21)":[140],"commercial":[142],"platforms":[143],"Predictor,":[146],"SwissADME,":[147],"pkCSM,":[148],"Derek":[149],"Nexus)":[150],"assessed":[152],"their":[154,223],"utility":[155],"data":[157,241,269],"curation":[158],"deployment":[160],"models.":[163],"Practical":[164],"applications":[165],"absorption":[167],"permeability,":[169],"P-gp":[170],"efflux),":[171],"distribution":[172],"(volume":[173],"plasma":[176],"protein":[177],"binding),":[178],"metabolism":[179],"(CYP450-mediated":[180],"biotransformation),":[181],"excretion":[183],"pathways":[184],"reviewed.":[186],"Toxicity":[187],"covers":[189],"acute":[190],"chronic":[192],"toxicity,":[193],"organ-specific":[194],"hepatotoxicity":[198],"cardiotoxicity,":[200],"long-term":[202],"risks":[203],"genotoxicity":[206],"carcinogenicity.":[208],"A":[209],"focused":[210],"section":[211],"provides":[212],"an":[213],"overview":[214],"ADME-":[216],"toxicity-specific":[218],"tools":[221],"integration":[224],"into":[225],"early-stage":[226],"pipelines":[229],"screening":[232],"high-risk":[234],"candidates.":[235],"Challenges":[236],"heterogeneity":[239],"quality,":[242],"model":[243],"interpretability,":[244],"translational":[246],"gaps":[247],"between":[248],"computational":[249],"predictions":[250],"vivo":[253],"outcomes":[254],"also":[256],"discussed.":[257],"Lastly,":[258],"it":[259],"discusses":[260],"new":[261],"trends":[262],"AI-based":[265],"multiparameter":[266],"optimization,":[267],"multi-omics":[268],"integration,":[270],"regulatory":[272],"approval,":[273],"putting":[274],"at":[281],"forefront":[283],"cutting-edge":[285],"innovation.":[287]},"counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2026-07-02T00:00:00"}
